UCSF

ZINC27558385

Substance Information

In ZINC since Heavy atoms Benign functionality
February 17th, 2009 27 No

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 2.46 11.31 -12.75 0 6 0 77 372.465 8
Lo Low (pH 4.5-6) 2.46 11.75 -42.37 1 6 1 78 373.473 8

Vendor Notes

Note Type Comments Provided By
PUBCHEM_PATENT_ID EP0769006A1; EP0769006B1; EP0992492A1; EP0998263A1; US5795908; US5859031; US5945441; US6140357; WO1996040633A1; WO1998055090A1; WO1999014998A2; WO2000009108A2; WO2000009124A1; WO2000016603A2 IBM Patent Data

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
FKB1A-1-E FK506-binding Protein 1A (cluster #1 Of 1), Eukaryotic Eukaryotes 9 0.42 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
FKB1A_HUMAN P62942 FK506-binding Protein 1A, Human 9 0.42 Binding ≤ 1μM
FKB1A_HUMAN P62942 FK506-binding Protein 1A, Human 9 0.42 Binding ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
TGF-beta receptor signaling activates SMADs
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
TGFBR1 KD Mutants in Cancer
TGFBR1 LBD Mutants in Cancer
TGFBR2 Kinase Domain Mutants in Cancer

Analogs ( Draw Identity 99% 90% 80% 70% )